BMY Bristol-Myers Squibb Company
22.45CAD-1.32%Mkt Cap: 32.64B $P/E: 3.571d ago
Industry Peers
Drug Manufacturers - General$1.13TUSDP/E 42.7
$621.22BUSDP/E 39.1
$503.27BUSDP/E 80.5
$384.25BUSDP/E 25.9
$379.21BUSDP/E 25.6
$369.78BUSDP/E 119.0
ROG
Roche Holding AG$353.89BUSDP/E 23.3
$292.80BUSDP/E 24.2
$292.58BUSDP/E 23.3
$261.61BUSDP/E 27.4
$261.25BUSDP/E 25.2
$236.98BUSDP/E 27.2
$261.10BUSDP/E 26.1
$190.42BUSD
$173.28BUSDP/E 9.8
$172.38BUSDP/E 9.2
$170.14BUSDP/E 39.3
$100.22BUSDP/E 15.8
$98.85BUSDP/E 22.6
$98.17BUSDP/E 21.6
Key Statistics
Company
Market Cap32.64B USD
Enterprise Value57.26B USD
Revenue (TTM)—
Gross Profit24.38B USD
Net Income (TTM)5.02B USD
Revenue/Share—
Last Price22.45 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)3.57
P/E (Forward)—
PEG—
EV/EBITDA4.25
EV/Revenue—
P/S0.93
P/B1.46
EPS (TTM)—
EPS (Forward)—
52W Range
22.450% of range22.75
52W High22.75 CAD
52W Low22.45 CAD
Profitability
Gross Margin71.08%
Oper. Margin—
EBITDA Margin—
Profit Margin14.64%
ROE38.19%
ROA7.83%
ROIC18.88%
ROCE20.60%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF10.07B USD
CapEx (TTM)933.04M USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity2.55
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)404
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—